1. Home
  2. PFSA vs CISS Comparison

PFSA vs CISS Comparison

Compare PFSA & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFSA

Profusa Inc.

HOLD

Current Price

$0.37

Market Cap

2.0M

Sector

Health Care

ML Signal

HOLD

Logo C3is Inc.

CISS

C3is Inc.

HOLD

Current Price

$2.44

Market Cap

1.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFSA
CISS
Founded
2009
2022
Country
United States
Greece
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0M
1.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
PFSA
CISS
Price
$0.37
$2.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
437.6K
1.2M
Earning Date
04-15-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.82
Revenue Growth
N/A
N/A
52 Week Low
$0.05
$0.08
52 Week High
$4.22
$6.06

Technical Indicators

Market Signals
Indicator
PFSA
CISS
Relative Strength Index (RSI) 36.11 47.28
Support Level $0.28 $2.04
Resistance Level $0.41 $2.81
Average True Range (ATR) 0.04 0.41
MACD 0.00 -0.17
Stochastic Oscillator 9.25 1.89

Price Performance

Historical Comparison
PFSA
CISS

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of its fleet is approximately 64,000 dwt.

Share on Social Networks: